C. Unaleroglu et al. / Tetrahedron: Asymmetry 17 (2006) 742–749
747
4.2.2.
2-Methyl-1-((1R)-1-phenylethyl)-1H-pyrrole-3-
by flash column chromatography (EtOAc/MeOH/
hexane, 1:1:6).
carbaldehyde, (R)-2. Light yellow solid (0.145 g,
68%), mp = 107–108 ꢁC. Rf = 0.71 (EtOAc/hexane,
25
1:3). ½aꢁD ¼ þ21:1 (c 0.8, CHCl3). IR (KBr): 3144,
4.3.1. (1S,2R)-2-((2-Methyl-1-((1S)-1-phenylethyl)-1H-
pyrrol-3-yl)methylamino)-1-phenylpropan-1-ol (1S,2R,S)-
2981, 2840, 1653, 1499, 1145, 1228, 1141, 1029 cmꢀ1
.
1H NMR (CDCl3) d (ppm): 1.76 (d, 3H, J = 7.1,
CHCH3), 2.34 (s, 3H, CH3), 5.27 (q, 1H, J = 7.0,
CHCH3), 6.51 (d, 1H, J = 3.2, CH-4), 6.67 (d, 1H,
J = 3.2, CH-5), 6.86 (d, 2H, J = 7.4, ArH), 6.94–7.43
(m, 3H, ArH), 9.76 (s, 1H, CHO). 13C NMR (CDCl3)
d (ppm): 12.2, 18.1, 54.8, 108.6, 118.6, 122.8, 125.3,
127.6, 128.7, 137.1, 141.9, 184.8 (C@O). Anal. Calcd
for C14H15NO: C, 78.84; H, 7.09; N, 6.57. Found: C,
78.60; H, 7.24; N, 6.45
4a. White solid (2.82 g, 69%), mp = 99.5–100.5 ꢁC.
25
Rf = 0.24 (EtOAc/MeOH/hexane, 1:1:6). ½aꢁD ¼ þ3:7
(c 11, CHCl3). IR (KBr): 3093, 3054, 2977, 2900, 1488,
1
1450, 1141, 1326, 1121, 1133 cmꢀ1. H NMR (CDCl3)
d (ppm): 0.81 (d, 3H, J = 6.8, CHCH3), 1.84 (d, 3H,
J = 7.2, NCHCH3), 2.08 (s, 3H, CH3), 3.00–3.06 (m,
1H, NHCHCH3), 3.73 (d, 1H, J = 12.8, NHCH2), 3.76
(d, 1H, J = 12.8, NHCH2), 4.79 (d, 1H, J = 3.6,
CHOH), 5.28 (q, 1H, J = 7.2, NCHCH3), 6.13 (d, 1H,
J = 3.2, CH), 6.77 (d, 1H, J = 3.2, CH), 6.97 (d, 2H,
J = 7.2, ArH), 7.13–7.31 (m, 8H, ArH). 13C NMR
(CDCl3) d (ppm): 10.4, 15.7, 22.8, 43.4, 55.5, 58.3,
72.6, 108.2, 116.9, 118.7, 125.1, 125.8, 125.9, 126.7,
127.1, 128.4, 129.0, 141.7, 144.0. Anal. Calcd for
C23H15N2O: C, 79.27; H, 8.10; N, 8.04. Found: C,
79.17; H, 7.99; N, 8.04.
4.2.3.
5-Methyl-1-((1S)-1-phenylethyl)-1H-pyrrole-2-
carbaldehyde, (S)-3. Brown oil (0.111 g, 52%).
25
Rf = 0.87 (EtOAc/hexane, 1:3). ½aꢁ ¼ ꢀ118:9 (c 11,
CHCl3). IR (KBr): 3026, 2973, 2807D, 2774, 1658, 1481,
1447, 1284, 1185, 1029 cmꢀ1 1H NMR (CDCl3) d
.
(ppm): 2.05 (d, 3H, J = 7.1, CHCH3), 2.12 (s, 3H,
CH3), 6.15 (d, 1H, J = 3.8, CH-4), 7.02 (d, 1H,
J = 3.9, CH-3), 7.13 (q, 1H, J = 7.0, CHCH3), 7.26 (d,
2H, J = 7.9, ArH) 7.36–7.47 (m, 3H, ArH), 9.60 (s,
1H, CHO). 13C NMR (CDCl3) d (ppm): 14.2, 18.5,
53.2, 111.6, 125.7, 126.1, 126.9, 128.1, 128.4, 132.2,
140.8, 141.2, 178.3 (C@O). Anal. Calcd for C14H15NO:
C, 78.84; H, 7.09; N, 6.57. Found: C, 78.72; H, 6.86;
N, 6.67.
4.3.2. (1R,2S)-2-((2-Methyl-1-((1R)-1-phenylethyl)-1H-
pyrrol-3-yl)methylamino)-1-phenylpropan-1-ol (1R,2S,R)-
4a. White solid (2.90 g, 71%), mp = 101–102 ꢁC.
25
Rf = 0.24 (EtOAc/MeOH/hexane, 1:1:6). ½aꢁD ¼ ꢀ3:2
(c 13, CHCl3). IR (KBr): 3060, 3027, 2977, 2900, 2830,
1486, 1444, 1411, 1322, 1241, 1132 cmꢀ1 1H NMR
.
(CDCl3) d (ppm): 0.81 (d, 3H, J = 6.5, CHCH3), 1.84
(d, 3H, J = 7.1, NCHCH3), 2.09 (s, 3H, CH3), 2.98–
3.04 (m, 1H, NHCHCH3), 3.72 (d, 1H, J = 12.9,
NHCH2), 3.77 (d, 1H, J = 12.9, NHCH2), 4.88 (d, 1H,
J = 4.0, CHOH), 5.28 (q, 1H, J = 7.2, NCHCH3), 6.14
(d, 1H, J = 2.8, CH), 6.78 (d, 1H, J = 2.8, CH), 6.96
(d, 2H, J = 7.2, ArH), 7.23–7.32 (m, 8H, ArH). 13C
NMR (CDCl3) d (ppm): 10.3, 14.7, 22.9, 43.6, 55.5,
58.1, 72.6, 107.9, 115.5, 118.9, 125.9, 127.1, 127.5,
128.3, 128.5, 129.1, 129.6, 141.9, 144.1.
4.2.4.
5-Methyl-1-((1R)-1-phenylethyl)-1H-pyrrole-2-
carbaldehyde, (R)-3. Brown oil (0.113 g, 53%).
25
Rf = 0.87 (EtOAc/hexane, 1:3). ½aꢁD ¼ þ119:7 (c 11,
CHCl3). IR (KBr): 3026, 2973, 2807, 2774, 1658, 1481,
1447, 1284, 1185, 1029 cmꢀ1 1H NMR (CDCl3) d
.
(ppm): 1.99 (d, 3H, J = 7.1, CHCH3), 2.06 (s, 3H,
CH3), 6.09 (d, 1H, J = 3.9, CH-4), 6.96 (d, 1H,
J = 3.9, CH-3), 7.15 (q, 1H, J = 6.8, CHCH3), 7.19 (d,
2H, J = 7.8, ArH), 7.26–7.57 (m, 3H, ArH), 9.54 (s,
1H, CHO). 13C NMR (CDCl3) d (ppm): 14.2, 18.5,
53.2, 111.6, 125.7, 126.1, 126.9, 128.4, 132.1, 140.8,
141.1, 178.2(C@O).
4.3.3. (1S,2R)-2-((2-Methyl-1-((1R)-1-phenylethyl)-1H-
pyrrol-3-yl)methylamino)-1-phenylpropan-1-ol (1S,2R,R)-
4b. Brown oil (2.98 g, 73%), Rf = 0.24 (EtOAc/
25
MeOH/hexane, 1:1:6). ½aꢁD ¼ þ5:6 (c 7.3, CHCl3); IR
(KBr): 3060, 2975, 2928, 1489, 1446, 1320, 1216 cmꢀ1
.
4.3. General procedure for the synthesis of pyrrole-based
derivatives of norephedrine
1H NMR (CDCl3) d (ppm): (400 MHz, CDCl3); 0.79
(d, 3H, J = 6.4, CHCH3), 1.96 (d, 3H, J = 7.2,
NHCHCH3), 1.98 (s, 3H, CH3), 2.95–3.01 (m, 1H,
NHCHCH3), 3.78 (d, 2H, J = 13.6, NHCH2), 3.85 (d,
1H, J = 13.6, NHCH2), 4.73 (d, 1H, J = 3.6, CHOH),
5.29 (q, 1H, J = 7.2, NCHCH3), 5.82 (d, 1H, J = 3.3,
CH), 6.00 (d, 1H, J = 3.4, CH), 7.07 (d, 2H, J = 7.2,
ArH), 7.22–7.34 (m, 8H, ArH). 13C NMR (CDCl3) d
(ppm): 10.3, 14.9, 22.8, 43.7, 55.5, 58.2, 72.9, 107.9,
116.6, 118.2, 125.9, 126.7, 126.7, 127.8, 128.8, 129.1,
129.9, 141.9, 144.1. Anal. Calcd for C23H15N2O: C,
79.27; H, 8.10; N, 8.04. Found: C, 79.10.; H, 8.05; N,
8.01.
Formylated pyrrole (2.5 g, 11.74 mmol) was dissolved in
10 mL dry benzene. To this solution was added norephe-
drine ( 1.76 g, 11.74 mmol) in 10 mL of dry benzene un-
der argon. The mixture was refluxed under a Dean Stark
trapp apparatus for 3 days, and the imine was then con-
centrated to dryness without purification. Imine (4.28 g,
12.36 mmol) in dry ether (10 mL) was added to the sus-
pension of LAH (0.54 g, 13.60 mmol) in dry ether
(50 mL). After the addition was completed, the mixture
was heated under argon for 10 h. The reaction was
quenched by sequential addition of water (15 mL),
15% NaOH (10 mL), and water (10 mL). The mixture
was filtered off and the white precipitate refluxed three
times with dry ether. The mixture was filtered off, the
organic layers combined, and dried over MgSO4. After
evaporation of solvent, the crude product was purified
4.3.4. (1R,2S)-2-((2-Methyl-1-((1S)-1-phenylethyl)-1H-
pyrrol-3-yl)methylamino)-1-phenylpropan-1-ol (1R,2S,S)-
4b. Brown oil (2.86 g, 70%). Rf = 0.24 (EtOAc/
25
MeOH/hexane, 1:1:6). ½aꢁD ¼ ꢀ4:5 (c 9.2, CHCl3), IR
(KBr): 3060, 3027, 2977, 2900–2830, 1492, 1450, 1323,